Teresita Bellido
Concepts (468)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 61 | 2023 | 213 | 13.680 |
Why?
| Bone and Bones | 42 | 2023 | 526 | 7.750 |
Why?
| Osteoblasts | 51 | 2022 | 531 | 5.630 |
Why?
| Bone Resorption | 26 | 2023 | 324 | 5.060 |
Why?
| Osteogenesis | 30 | 2022 | 382 | 5.010 |
Why?
| Signal Transduction | 39 | 2022 | 1855 | 4.370 |
Why?
| Bone Remodeling | 21 | 2022 | 178 | 4.210 |
Why?
| Parathyroid Hormone | 15 | 2022 | 219 | 4.200 |
Why?
| Osteoclasts | 32 | 2023 | 468 | 4.040 |
Why?
| Apoptosis | 32 | 2017 | 1359 | 3.350 |
Why?
| Glucocorticoids | 11 | 2019 | 243 | 3.200 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 9 | 2022 | 32 | 3.130 |
Why?
| Mice | 86 | 2023 | 6500 | 2.350 |
Why?
| Receptors, Notch | 5 | 2022 | 33 | 2.340 |
Why?
| Animals | 114 | 2023 | 14855 | 2.320 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 66 | 2.210 |
Why?
| Connexin 43 | 13 | 2017 | 24 | 2.140 |
Why?
| RANK Ligand | 10 | 2018 | 186 | 2.120 |
Why?
| Glycoproteins | 15 | 2019 | 138 | 2.060 |
Why?
| Diphosphonates | 8 | 2012 | 94 | 2.040 |
Why?
| Mechanotransduction, Cellular | 10 | 2016 | 38 | 1.990 |
Why?
| Wnt Signaling Pathway | 10 | 2022 | 98 | 1.980 |
Why?
| Antioxidants | 4 | 2020 | 305 | 1.690 |
Why?
| beta Catenin | 8 | 2022 | 103 | 1.650 |
Why?
| Adaptor Proteins, Signal Transducing | 19 | 2020 | 215 | 1.540 |
Why?
| Osteoporosis | 7 | 2016 | 175 | 1.400 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 10 | 2013 | 109 | 1.390 |
Why?
| Intercellular Signaling Peptides and Proteins | 16 | 2019 | 127 | 1.250 |
Why?
| NF-E2-Related Factor 2 | 2 | 2017 | 66 | 1.150 |
Why?
| Focal Adhesion Kinase 2 | 3 | 2019 | 15 | 1.150 |
Why?
| Mice, Inbred C57BL | 20 | 2022 | 2072 | 1.120 |
Why?
| Mice, Knockout | 17 | 2022 | 1010 | 1.120 |
Why?
| Cells, Cultured | 28 | 2018 | 1817 | 1.110 |
Why?
| Bone Density | 18 | 2023 | 422 | 1.070 |
Why?
| Anoikis | 2 | 2019 | 9 | 1.060 |
Why?
| Receptors, Parathyroid Hormone | 3 | 2014 | 25 | 0.980 |
Why?
| Aging | 6 | 2018 | 789 | 0.830 |
Why?
| Mice, Transgenic | 11 | 2015 | 721 | 0.830 |
Why?
| Cell Differentiation | 11 | 2021 | 755 | 0.830 |
Why?
| Bone Marrow | 6 | 2016 | 412 | 0.790 |
Why?
| Calcitriol | 10 | 2005 | 48 | 0.780 |
Why?
| Weight-Bearing | 6 | 2016 | 66 | 0.770 |
Why?
| Cell Survival | 12 | 2019 | 692 | 0.760 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2023 | 136 | 0.760 |
Why?
| Cell Communication | 3 | 2022 | 70 | 0.740 |
Why?
| Wnt Proteins | 7 | 2013 | 111 | 0.730 |
Why?
| Alendronate | 7 | 2015 | 20 | 0.690 |
Why?
| Stress, Mechanical | 5 | 2013 | 108 | 0.690 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 6 | 0.660 |
Why?
| Interleukin-6 | 10 | 1998 | 321 | 0.650 |
Why?
| Female | 39 | 2023 | 29351 | 0.630 |
Why?
| Bone Density Conservation Agents | 6 | 2021 | 82 | 0.610 |
Why?
| Bone Marrow Cells | 9 | 2021 | 236 | 0.610 |
Why?
| Adipogenesis | 1 | 2017 | 56 | 0.610 |
Why?
| Collagen Type I | 4 | 2015 | 99 | 0.610 |
Why?
| ortho-Aminobenzoates | 1 | 2016 | 9 | 0.600 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2016 | 35 | 0.600 |
Why?
| Muscular Atrophy | 1 | 2017 | 75 | 0.590 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 103 | 0.590 |
Why?
| Fracture Healing | 1 | 2016 | 27 | 0.590 |
Why?
| Fibroblast Growth Factors | 3 | 2017 | 63 | 0.580 |
Why?
| Down-Regulation | 7 | 2017 | 405 | 0.580 |
Why?
| Adipocytes | 1 | 2017 | 143 | 0.570 |
Why?
| Cellular Microenvironment | 1 | 2016 | 28 | 0.560 |
Why?
| Fractures, Bone | 2 | 2016 | 125 | 0.560 |
Why?
| Organ Size | 6 | 2019 | 252 | 0.560 |
Why?
| Humans | 58 | 2022 | 54818 | 0.550 |
Why?
| Caveolin 1 | 2 | 2013 | 21 | 0.550 |
Why?
| Peptides | 4 | 2015 | 288 | 0.550 |
Why?
| Estrogen Receptor beta | 3 | 2022 | 60 | 0.540 |
Why?
| Extracellular Matrix Proteins | 6 | 2022 | 80 | 0.530 |
Why?
| Periosteum | 2 | 2012 | 20 | 0.520 |
Why?
| Models, Biological | 10 | 2016 | 857 | 0.520 |
Why?
| Mitogen-Activated Protein Kinases | 4 | 2004 | 177 | 0.510 |
Why?
| Genetic Markers | 8 | 2020 | 119 | 0.510 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 4 | 2023 | 7 | 0.510 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 117 | 0.490 |
Why?
| Gap Junctions | 2 | 2017 | 27 | 0.490 |
Why?
| Gene Deletion | 7 | 2019 | 293 | 0.490 |
Why?
| Hematopoietic Stem Cells | 2 | 2012 | 217 | 0.480 |
Why?
| Estrogens | 6 | 2007 | 266 | 0.480 |
Why?
| MAP Kinase Signaling System | 3 | 2012 | 139 | 0.470 |
Why?
| Multiple Myeloma | 5 | 2022 | 2884 | 0.460 |
Why?
| Phosphorylation | 12 | 2014 | 637 | 0.460 |
Why?
| Muscles | 5 | 1993 | 112 | 0.460 |
Why?
| Phosphates | 5 | 2016 | 50 | 0.450 |
Why?
| Cell Line | 16 | 2014 | 1200 | 0.450 |
Why?
| Hyperostosis | 2 | 2022 | 4 | 0.420 |
Why?
| Up-Regulation | 7 | 2014 | 528 | 0.420 |
Why?
| RNA, Messenger | 8 | 2017 | 1296 | 0.420 |
Why?
| Enzyme Inhibitors | 6 | 2014 | 455 | 0.410 |
Why?
| Phosphoproteins | 3 | 2018 | 121 | 0.400 |
Why?
| Enzyme Activation | 9 | 2010 | 342 | 0.390 |
Why?
| Gene Expression Regulation | 8 | 2017 | 1146 | 0.380 |
Why?
| Gene Expression | 5 | 2017 | 719 | 0.380 |
Why?
| Estrogen Receptor alpha | 3 | 2022 | 112 | 0.370 |
Why?
| Focal Adhesion Kinase 1 | 2 | 2007 | 14 | 0.370 |
Why?
| X-Ray Microtomography | 6 | 2022 | 70 | 0.360 |
Why?
| Receptors, Estrogen | 6 | 2022 | 151 | 0.350 |
Why?
| MicroRNAs | 3 | 2019 | 385 | 0.340 |
Why?
| src-Family Kinases | 3 | 2005 | 58 | 0.340 |
Why?
| Cytokines | 7 | 2014 | 706 | 0.340 |
Why?
| Cell Membrane | 2 | 2007 | 279 | 0.330 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2023 | 197 | 0.320 |
Why?
| Monocytes | 1 | 2008 | 163 | 0.310 |
Why?
| Weightlessness | 1 | 2006 | 15 | 0.300 |
Why?
| Osteolysis | 3 | 2022 | 92 | 0.290 |
Why?
| Osteoprotegerin | 2 | 2016 | 47 | 0.290 |
Why?
| Membrane Glycoproteins | 5 | 2003 | 278 | 0.290 |
Why?
| Protein-Tyrosine Kinases | 3 | 2010 | 106 | 0.290 |
Why?
| Calcifediol | 4 | 1991 | 10 | 0.280 |
Why?
| HeLa Cells | 10 | 2017 | 288 | 0.280 |
Why?
| Male | 21 | 2022 | 28250 | 0.280 |
Why?
| Cell Nucleus | 5 | 2013 | 211 | 0.280 |
Why?
| Dexamethasone | 6 | 2017 | 419 | 0.280 |
Why?
| Transcription Factors | 3 | 2004 | 645 | 0.270 |
Why?
| Integrins | 1 | 2005 | 43 | 0.270 |
Why?
| Caspases | 3 | 2006 | 154 | 0.270 |
Why?
| Skull | 5 | 2015 | 80 | 0.270 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 25 | 0.260 |
Why?
| Caspase 3 | 5 | 2017 | 140 | 0.250 |
Why?
| Multienzyme Complexes | 1 | 2003 | 45 | 0.240 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 75 | 0.240 |
Why?
| Antigens, CD | 4 | 2000 | 247 | 0.240 |
Why?
| Calcium Channels | 2 | 2001 | 63 | 0.240 |
Why?
| Gingivitis | 1 | 2023 | 2 | 0.240 |
Why?
| Estradiol | 8 | 2007 | 244 | 0.240 |
Why?
| Alveolar Bone Loss | 1 | 2023 | 13 | 0.240 |
Why?
| Rats | 9 | 2014 | 3547 | 0.240 |
Why?
| Osteoporosis, Postmenopausal | 3 | 2014 | 34 | 0.230 |
Why?
| Periodontitis | 1 | 2023 | 10 | 0.230 |
Why?
| Actins | 2 | 2005 | 137 | 0.230 |
Why?
| Kinetics | 8 | 2004 | 697 | 0.230 |
Why?
| Protein Kinases | 2 | 2014 | 97 | 0.230 |
Why?
| Tuberous Sclerosis | 1 | 2022 | 37 | 0.220 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 2016 | 444 | 0.220 |
Why?
| Phosphotyrosine | 2 | 1999 | 9 | 0.220 |
Why?
| Tumor Suppressor Proteins | 1 | 2022 | 144 | 0.220 |
Why?
| Transfection | 6 | 2007 | 435 | 0.210 |
Why?
| Bone Matrix | 2 | 2019 | 22 | 0.210 |
Why?
| Disease Models, Animal | 6 | 2021 | 1716 | 0.210 |
Why?
| Receptors, Androgen | 3 | 2006 | 53 | 0.200 |
Why?
| Dihydrotestosterone | 3 | 2006 | 15 | 0.200 |
Why?
| Transcription, Genetic | 7 | 2006 | 455 | 0.200 |
Why?
| Neoplasm Proteins | 1 | 2003 | 376 | 0.200 |
Why?
| Trans-Activators | 3 | 2018 | 156 | 0.200 |
Why?
| Mutation | 5 | 2023 | 1437 | 0.190 |
Why?
| Dentin | 1 | 2019 | 6 | 0.190 |
Why?
| Calcitonin | 1 | 1999 | 40 | 0.190 |
Why?
| Phenotype | 3 | 2020 | 843 | 0.190 |
Why?
| Cell Division | 5 | 2005 | 344 | 0.180 |
Why?
| Lymphokines | 2 | 1997 | 22 | 0.180 |
Why?
| Phylogeny | 1 | 2020 | 288 | 0.180 |
Why?
| Growth Inhibitors | 2 | 1997 | 34 | 0.180 |
Why?
| Ovariectomy | 4 | 2014 | 132 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1537 | 0.180 |
Why?
| DNA-Binding Proteins | 3 | 2003 | 498 | 0.180 |
Why?
| Cell Proliferation | 2 | 2016 | 1134 | 0.180 |
Why?
| Receptors, Interleukin-17 | 1 | 2018 | 2 | 0.180 |
Why?
| Dental Cementum | 1 | 2018 | 1 | 0.180 |
Why?
| Tooth Ankylosis | 1 | 2018 | 1 | 0.180 |
Why?
| Protein Binding | 4 | 2011 | 768 | 0.180 |
Why?
| Gonadal Steroid Hormones | 3 | 2007 | 46 | 0.180 |
Why?
| Anabolic Agents | 1 | 2019 | 38 | 0.170 |
Why?
| Bone Diseases | 2 | 2017 | 105 | 0.170 |
Why?
| Tretinoin | 1 | 1999 | 59 | 0.170 |
Why?
| Mefloquine | 1 | 2018 | 5 | 0.170 |
Why?
| Cyclins | 1 | 1998 | 55 | 0.170 |
Why?
| Primary Cell Culture | 2 | 2017 | 68 | 0.170 |
Why?
| Chick Embryo | 6 | 2001 | 74 | 0.160 |
Why?
| Culture Media, Conditioned | 3 | 2023 | 52 | 0.160 |
Why?
| Absorptiometry, Photon | 2 | 2019 | 175 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 706 | 0.160 |
Why?
| Repressor Proteins | 1 | 2019 | 172 | 0.160 |
Why?
| Bone Development | 1 | 2018 | 71 | 0.160 |
Why?
| Femur | 2 | 2015 | 150 | 0.160 |
Why?
| Nuclear Respiratory Factor 1 | 1 | 2017 | 2 | 0.160 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 16 | 0.160 |
Why?
| Glucuronidase | 1 | 2017 | 47 | 0.160 |
Why?
| Osteoporotic Fractures | 1 | 2017 | 14 | 0.160 |
Why?
| Mice, 129 Strain | 1 | 2017 | 52 | 0.160 |
Why?
| Hyponatremia | 1 | 2017 | 15 | 0.150 |
Why?
| Oxidative Stress | 2 | 2017 | 972 | 0.150 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 127 | 0.150 |
Why?
| Calcium | 4 | 2023 | 451 | 0.150 |
Why?
| Teriparatide | 2 | 2011 | 17 | 0.150 |
Why?
| Hypophosphatemia, Familial | 1 | 2016 | 1 | 0.150 |
Why?
| Cyclin D1 | 1 | 2016 | 63 | 0.150 |
Why?
| Receptors, Interleukin | 1 | 1996 | 11 | 0.150 |
Why?
| Immunohistochemistry | 3 | 2017 | 1123 | 0.150 |
Why?
| Receptors, Nerve Growth Factor | 1 | 1996 | 6 | 0.150 |
Why?
| Receptors, Cytokine | 1 | 1996 | 14 | 0.150 |
Why?
| Diet | 1 | 2020 | 612 | 0.150 |
Why?
| Etoposide | 4 | 2005 | 80 | 0.150 |
Why?
| Integrases | 2 | 2022 | 48 | 0.150 |
Why?
| Random Allocation | 1 | 2017 | 323 | 0.150 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2010 | 21 | 0.140 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 79 | 0.140 |
Why?
| Hindlimb | 1 | 2015 | 26 | 0.140 |
Why?
| Protein Structure, Tertiary | 4 | 2015 | 292 | 0.140 |
Why?
| Peptide Fragments | 3 | 2015 | 269 | 0.140 |
Why?
| Core Binding Factor Alpha 1 Subunit | 2 | 2006 | 50 | 0.140 |
Why?
| Hindlimb Suspension | 1 | 2015 | 50 | 0.140 |
Why?
| Hematopoiesis | 2 | 2014 | 85 | 0.140 |
Why?
| Adiposity | 1 | 2016 | 149 | 0.140 |
Why?
| Sex Characteristics | 1 | 2017 | 208 | 0.140 |
Why?
| Mutation, Missense | 1 | 2015 | 116 | 0.130 |
Why?
| Homeostasis | 2 | 2012 | 234 | 0.130 |
Why?
| Testosterone | 1 | 1995 | 128 | 0.130 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.130 |
Why?
| Promoter Regions, Genetic | 3 | 2008 | 564 | 0.130 |
Why?
| Receptors, Calcitriol | 3 | 2005 | 29 | 0.130 |
Why?
| Time Factors | 7 | 2015 | 3379 | 0.130 |
Why?
| Nucleic Acid Synthesis Inhibitors | 2 | 2005 | 17 | 0.130 |
Why?
| Protein Kinase C | 2 | 2003 | 75 | 0.130 |
Why?
| Sirtuin 1 | 1 | 2014 | 29 | 0.130 |
Why?
| Organ Culture Techniques | 1 | 2014 | 55 | 0.130 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 29 | 0.130 |
Why?
| Myeloproliferative Disorders | 1 | 2014 | 26 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 157 | 0.130 |
Why?
| Lymphoid Tissue | 1 | 1994 | 25 | 0.130 |
Why?
| LDL-Receptor Related Proteins | 2 | 2011 | 12 | 0.130 |
Why?
| Receptors, Steroid | 1 | 1993 | 28 | 0.120 |
Why?
| Injections, Subcutaneous | 1 | 2013 | 60 | 0.120 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 169 | 0.120 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 71 | 0.120 |
Why?
| Blotting, Western | 5 | 2011 | 711 | 0.120 |
Why?
| Transcriptome | 1 | 2016 | 360 | 0.120 |
Why?
| Receptor Cross-Talk | 1 | 2013 | 6 | 0.120 |
Why?
| TCF Transcription Factors | 1 | 2013 | 11 | 0.120 |
Why?
| Osteocalcin | 2 | 2014 | 46 | 0.120 |
Why?
| Hematologic Neoplasms | 1 | 2014 | 98 | 0.120 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 130 | 0.110 |
Why?
| Flavonoids | 1 | 2013 | 65 | 0.110 |
Why?
| Ulna | 2 | 2013 | 15 | 0.110 |
Why?
| Protein Transport | 1 | 2013 | 197 | 0.110 |
Why?
| RNA, Small Interfering | 1 | 2013 | 271 | 0.110 |
Why?
| Arrestins | 1 | 2011 | 1 | 0.110 |
Why?
| Societies, Scientific | 1 | 2011 | 15 | 0.110 |
Why?
| Transgenes | 1 | 2011 | 60 | 0.110 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 167 | 0.110 |
Why?
| Absorption | 1 | 2011 | 24 | 0.110 |
Why?
| Flow Cytometry | 2 | 2012 | 572 | 0.110 |
Why?
| Health | 1 | 2011 | 29 | 0.110 |
Why?
| Minerals | 1 | 2011 | 38 | 0.110 |
Why?
| Ligands | 3 | 2007 | 253 | 0.110 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 185 | 0.100 |
Why?
| Lumbar Vertebrae | 2 | 2018 | 120 | 0.100 |
Why?
| Etidronic Acid | 2 | 2001 | 6 | 0.100 |
Why?
| Cytokine Receptor gp130 | 4 | 2000 | 14 | 0.100 |
Why?
| Muscle, Skeletal | 1 | 2017 | 824 | 0.100 |
Why?
| Estrogen Antagonists | 2 | 2007 | 22 | 0.090 |
Why?
| Extracellular Matrix | 1 | 2010 | 113 | 0.090 |
Why?
| Spine | 1 | 2010 | 123 | 0.090 |
Why?
| Hormones | 2 | 2008 | 63 | 0.090 |
Why?
| Dactinomycin | 2 | 2003 | 23 | 0.090 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 112 | 0.090 |
Why?
| Gene Silencing | 1 | 2008 | 131 | 0.080 |
Why?
| Biomedical Research | 1 | 2011 | 247 | 0.080 |
Why?
| Nifedipine | 2 | 2001 | 24 | 0.080 |
Why?
| Molecular Structure | 2 | 2006 | 325 | 0.080 |
Why?
| Estrenes | 2 | 2006 | 12 | 0.080 |
Why?
| Base Sequence | 4 | 1998 | 765 | 0.080 |
Why?
| Phospholipids | 1 | 1987 | 65 | 0.080 |
Why?
| Stem Cells | 2 | 2006 | 201 | 0.080 |
Why?
| Dihydroxycholecalciferols | 1 | 1987 | 4 | 0.080 |
Why?
| Cattle | 1 | 2008 | 239 | 0.080 |
Why?
| Tibia | 1 | 2007 | 120 | 0.080 |
Why?
| bcl-Associated Death Protein | 2 | 2003 | 14 | 0.080 |
Why?
| Weight Gain | 1 | 2008 | 234 | 0.080 |
Why?
| Leukemia Inhibitory Factor | 2 | 1997 | 17 | 0.080 |
Why?
| Genotype | 1 | 2008 | 632 | 0.080 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 64 | 0.080 |
Why?
| Membrane Proteins | 1 | 1989 | 387 | 0.080 |
Why?
| Fatty Acids | 1 | 1987 | 181 | 0.080 |
Why?
| Spleen | 1 | 2008 | 192 | 0.080 |
Why?
| Disease Progression | 2 | 2021 | 919 | 0.070 |
Why?
| Cell Count | 1 | 2006 | 186 | 0.070 |
Why?
| RNA | 2 | 2005 | 197 | 0.070 |
Why?
| Kidney | 1 | 2011 | 839 | 0.070 |
Why?
| Caveolae | 1 | 2005 | 6 | 0.070 |
Why?
| Injections | 1 | 2005 | 64 | 0.070 |
Why?
| Physical Stimulation | 1 | 2005 | 36 | 0.070 |
Why?
| beta-Cyclodextrins | 1 | 2005 | 17 | 0.070 |
Why?
| Tubulin | 1 | 2005 | 29 | 0.070 |
Why?
| src Homology Domains | 2 | 2001 | 9 | 0.070 |
Why?
| Cytoskeleton | 1 | 2005 | 52 | 0.070 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 39 | 0.070 |
Why?
| Cycloheximide | 3 | 2005 | 33 | 0.070 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 8 | 0.070 |
Why?
| Cell Line, Tumor | 2 | 2021 | 1542 | 0.070 |
Why?
| Carrier Proteins | 2 | 2003 | 392 | 0.060 |
Why?
| Drug Synergism | 1 | 2004 | 173 | 0.060 |
Why?
| Drug Administration Schedule | 1 | 2005 | 418 | 0.060 |
Why?
| Receptors, Interleukin-6 | 3 | 2000 | 29 | 0.060 |
Why?
| Binding Sites | 3 | 2012 | 464 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 217 | 0.060 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 33 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 34 | 0.060 |
Why?
| Carcinogens | 1 | 2005 | 237 | 0.060 |
Why?
| CD40 Ligand | 1 | 2003 | 18 | 0.060 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2023 | 1 | 0.060 |
Why?
| Alveolar Process | 1 | 2023 | 12 | 0.060 |
Why?
| DNA | 3 | 2005 | 588 | 0.060 |
Why?
| NF-kappa B | 2 | 2014 | 355 | 0.060 |
Why?
| Models, Genetic | 1 | 2003 | 210 | 0.060 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 135 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 159 | 0.060 |
Why?
| Fibroblasts | 2 | 2001 | 378 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2022 | 83 | 0.060 |
Why?
| Fluorescent Dyes | 1 | 2023 | 123 | 0.060 |
Why?
| Embryo, Mammalian | 1 | 2001 | 79 | 0.050 |
Why?
| Luminescent Proteins | 1 | 2001 | 68 | 0.050 |
Why?
| Clodronic Acid | 1 | 2021 | 20 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2001 | 73 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 262 | 0.050 |
Why?
| STAT3 Transcription Factor | 2 | 2000 | 91 | 0.050 |
Why?
| Interleukin-5 | 1 | 2000 | 7 | 0.050 |
Why?
| Cell-Free System | 1 | 2000 | 15 | 0.050 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 222 | 0.050 |
Why?
| Odontogenesis | 1 | 2019 | 1 | 0.050 |
Why?
| Odontoblasts | 1 | 2019 | 5 | 0.050 |
Why?
| Dental Pulp | 1 | 2019 | 3 | 0.050 |
Why?
| In Situ Nick-End Labeling | 1 | 1999 | 66 | 0.050 |
Why?
| Recombinant Proteins | 2 | 1998 | 583 | 0.050 |
Why?
| Prednisolone | 1 | 1999 | 58 | 0.050 |
Why?
| Semaphorins | 1 | 2019 | 3 | 0.050 |
Why?
| Rifabutin | 1 | 1999 | 5 | 0.050 |
Why?
| Lactams, Macrocyclic | 1 | 1999 | 13 | 0.050 |
Why?
| Isotretinoin | 1 | 1999 | 9 | 0.050 |
Why?
| Quinones | 1 | 1999 | 10 | 0.050 |
Why?
| Benzoquinones | 1 | 1999 | 33 | 0.040 |
Why?
| Periodontal Ligament | 1 | 2018 | 2 | 0.040 |
Why?
| Tooth Eruption | 1 | 2018 | 2 | 0.040 |
Why?
| Transcription Factor AP-1 | 1 | 2019 | 66 | 0.040 |
Why?
| Sodium | 2 | 1991 | 102 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2015 | 90 | 0.040 |
Why?
| Cell Adhesion Molecules | 1 | 1999 | 94 | 0.040 |
Why?
| Biological Transport | 2 | 1991 | 196 | 0.040 |
Why?
| Interleukin-17 | 1 | 2018 | 39 | 0.040 |
Why?
| Oligonucleotides, Antisense | 1 | 1998 | 31 | 0.040 |
Why?
| Cytoplasm | 3 | 2004 | 109 | 0.040 |
Why?
| Growth Substances | 1 | 1998 | 37 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 96 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 1999 | 495 | 0.040 |
Why?
| Hyperparathyroidism, Primary | 1 | 2018 | 53 | 0.040 |
Why?
| Connective Tissue Cells | 1 | 1997 | 1 | 0.040 |
Why?
| Ciliary Neurotrophic Factor | 1 | 1997 | 11 | 0.040 |
Why?
| Inflammation | 1 | 2023 | 704 | 0.040 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 42 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 1995 | 1044 | 0.040 |
Why?
| Osteogenesis Imperfecta | 1 | 2018 | 40 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1997 | 31 | 0.040 |
Why?
| Endometrial Neoplasms | 1 | 1999 | 156 | 0.040 |
Why?
| HMGB1 Protein | 1 | 2017 | 17 | 0.040 |
Why?
| Genetic Complementation Test | 1 | 2017 | 50 | 0.040 |
Why?
| Analysis of Variance | 1 | 1999 | 669 | 0.040 |
Why?
| Alkaline Phosphatase | 1 | 1997 | 102 | 0.040 |
Why?
| Proto-Oncogene Proteins | 3 | 2005 | 176 | 0.040 |
Why?
| Body Weight | 1 | 2019 | 600 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 1995 | 202 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 70 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1994 | 50 | 0.040 |
Why?
| Tumor Suppressor Protein p53 | 1 | 1998 | 261 | 0.040 |
Why?
| Receptor, Ciliary Neurotrophic Factor | 1 | 1996 | 1 | 0.040 |
Why?
| Receptors, Interleukin-11 | 1 | 1996 | 1 | 0.040 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 1996 | 1 | 0.040 |
Why?
| Receptors, Oncostatin M | 1 | 1996 | 2 | 0.040 |
Why?
| Receptors, OSM-LIF | 1 | 1996 | 3 | 0.040 |
Why?
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1996 | 3 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2018 | 211 | 0.040 |
Why?
| Gait | 1 | 2017 | 93 | 0.040 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 30 | 0.040 |
Why?
| Biological Assay | 1 | 1996 | 60 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 213 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2015 | 110 | 0.030 |
Why?
| X-Rays | 1 | 2015 | 57 | 0.030 |
Why?
| Orchiectomy | 1 | 1995 | 40 | 0.030 |
Why?
| Genetic Loci | 1 | 2015 | 63 | 0.030 |
Why?
| Accidental Falls | 1 | 2017 | 115 | 0.030 |
Why?
| Epigenetic Repression | 1 | 2014 | 1 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2015 | 218 | 0.030 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 2 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2014 | 10 | 0.030 |
Why?
| Steroids | 1 | 1995 | 52 | 0.030 |
Why?
| Lymphocytes | 1 | 1995 | 177 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 429 | 0.030 |
Why?
| Androgens | 2 | 2007 | 72 | 0.030 |
Why?
| Antigens, Differentiation | 1 | 2014 | 26 | 0.030 |
Why?
| Adjuvants, Immunologic | 1 | 1994 | 62 | 0.030 |
Why?
| Antibodies, Neutralizing | 1 | 2014 | 76 | 0.030 |
Why?
| Plasmids | 2 | 2004 | 190 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2014 | 145 | 0.030 |
Why?
| Bucladesine | 1 | 1993 | 5 | 0.030 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1993 | 10 | 0.030 |
Why?
| Staurosporine | 1 | 1993 | 14 | 0.030 |
Why?
| Diglycerides | 1 | 1993 | 14 | 0.030 |
Why?
| Alkaloids | 1 | 1993 | 37 | 0.030 |
Why?
| Algorithms | 1 | 2017 | 703 | 0.030 |
Why?
| Body Composition | 1 | 2015 | 355 | 0.030 |
Why?
| Haversian System | 1 | 2012 | 1 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 572 | 0.030 |
Why?
| Vanadates | 1 | 2012 | 14 | 0.030 |
Why?
| Transforming Growth Factor beta | 2 | 2006 | 174 | 0.030 |
Why?
| Binding, Competitive | 1 | 2012 | 129 | 0.030 |
Why?
| Heart | 1 | 1994 | 363 | 0.030 |
Why?
| Tissue Distribution | 1 | 2012 | 190 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2011 | 76 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1993 | 555 | 0.030 |
Why?
| Ion Channels | 1 | 2012 | 76 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1415 | 0.030 |
Why?
| Spectrometry, X-Ray Emission | 1 | 2011 | 9 | 0.030 |
Why?
| Phosphorus Radioisotopes | 1 | 1991 | 20 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2011 | 113 | 0.030 |
Why?
| Cholecalciferol | 1 | 1991 | 21 | 0.030 |
Why?
| Rats, Long-Evans | 1 | 2011 | 29 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2011 | 95 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 215 | 0.030 |
Why?
| Rabbits | 1 | 2012 | 452 | 0.020 |
Why?
| Spectrum Analysis, Raman | 1 | 2011 | 73 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2011 | 119 | 0.020 |
Why?
| Motor Activity | 1 | 2011 | 261 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 892 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2014 | 1754 | 0.020 |
Why?
| Physical Exertion | 1 | 2009 | 69 | 0.020 |
Why?
| Leucine | 1 | 1989 | 106 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1299 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2007 | 85 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2007 | 73 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 581 | 0.020 |
Why?
| Weightlessness Simulation | 1 | 2007 | 25 | 0.020 |
Why?
| Risk Factors | 1 | 2017 | 4070 | 0.020 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 3 | 0.020 |
Why?
| Smad Proteins | 1 | 2006 | 14 | 0.020 |
Why?
| Response Elements | 1 | 2006 | 35 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2006 | 53 | 0.020 |
Why?
| Vitamin D Deficiency | 1 | 1987 | 52 | 0.020 |
Why?
| Chickens | 1 | 1987 | 122 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 8 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 21 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 12 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 20 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 102 | 0.020 |
Why?
| Cholera Toxin | 1 | 2004 | 16 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2005 | 34 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 48 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 57 | 0.020 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 46 | 0.020 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 12 | 0.020 |
Why?
| Caspase Inhibitors | 1 | 2003 | 34 | 0.020 |
Why?
| Tensile Strength | 1 | 2003 | 35 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 4 | 0.020 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 6 | 0.020 |
Why?
| Phosphotransferases | 1 | 2003 | 24 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 68 | 0.010 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 28 | 0.010 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 84 | 0.010 |
Why?
| Genes, Reporter | 1 | 2003 | 103 | 0.010 |
Why?
| Oncostatin M | 1 | 2000 | 5 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 52 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2001 | 147 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 807 | 0.010 |
Why?
| Stromal Cells | 1 | 1997 | 95 | 0.010 |
Why?
| Proto-Oncogene Proteins c-rel | 1 | 1995 | 5 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1995 | 31 | 0.010 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 12 | 0.010 |
Why?
| Myocardium | 1 | 1994 | 453 | 0.010 |
Why?
| Adult | 1 | 1995 | 14619 | 0.000 |
Why?
|
|
Bellido's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|